Global  

Asian stocks rise after Moderna's coronavirus vaccine delivers early positive results

Business Insider Tuesday, 19 May 2020
Asian stocks rise after Moderna's coronavirus vaccine delivers early positive results· *Asian stocks rose on Tuesday after Moderna reported promising results from the first human trials of its coronavirus vaccine.*
· *US futures slid after US President Donald Trump threatened to terminate funding to the World Health Organization unless it makes "substantive improvements" following its response to the...
0
shares
ShareTweetSavePostSend
 

Related videos from verified sources

Equity indices up on vaccine hopes, banking and financial stocks gain [Video]

Equity indices up on vaccine hopes, banking and financial stocks gain

Equity benchmark indices were up by nearly one per cent during early hours on July 02 tracking gains in Asian peers as investors hoped of a vaccine for COVID-19. At 10:15 am, the BSE SandP Sensex was..

Credit: ANI     Duration: 01:50Published
Greenville clinic selected to run COVID-19 vaccine trial [Video]

Greenville clinic selected to run COVID-19 vaccine trial

Vitalink Research was selected by Moderna to run the trial.

Credit: WYFF     Duration: 01:27Published
U.S. Physicians Skeptical Of COVID-19 Medication Breakthrough [Video]

U.S. Physicians Skeptical Of COVID-19 Medication Breakthrough

Reports of a powerful treatment for the new coronavirus has brought waves of skepticism among U.S. doctors. Trial results announced on Tuesday showed dexamethasone cut COVID-19 death rates by around a..

Credit: Wochit     Duration: 00:32Published

Related news from verified sources

10 things you need to know before the opening bell

10 things you need to know before the opening bell
Here's what you need to know before the markets open. 1. *Asian stocks rise after Moderna's coronavirus vaccine delivers early positive results**. *US...
Business Insider

Asian Markets Mostly Lower

Asian stock markets are mostly lower on Wednesday after a report from medical news website STAT raised concerns about the trial results of biotech company...
RTTNews

Moderna hit by criticism over lack of data on coronavirus vaccine candidate results

Moderna Inc (NASDAQ:MRNA) was lower in premarket New York trading on Wednesday as the stock still suffers criticism over the most recent results for its...
Proactive Investors


Tweets about this